Thracheal hystoplasmosis Case report Clínica Marly Bogotá, Colombia
Histoplasmosis traqueal Reporte de un caso en la Clínica de Marly Bogotá, Colombia
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.
Show authors biography
Is the case of a 76 year old patient diagnosed with COPD a few years ago, having recurrent episodes in treatment with bronchodilators and steroids. The patient was sent to Clínica Marly with an 80% upper airway obstruction. The treatment initially included laser therapy and biopsies of the obstruction. The therapy was successful and the histological findings were compatible with tracheal histoplasmosis. Thoracic and abdominal CAT Scans were performed without pathological findings. A systematic research for tracheal histoplasmosis was made and there weren’t any specific articles on the subject in world literature. Upper airway histoplasmosis includes lesions in head, neck, larynx and oral cavity in that the host has any case of immunosupression and begins with disseminated disease. Upper airway histoplasmosis produces dysphonia, dyspnea and usually dysphagia. The oral mucous, tongue and larynx are the usual places of presentation of the disease in this location. Nodular disease is present in some structures
with or without neck lymph nodes. The goal of treatment is to reduce mortality and complications. B Amphotericin is the first choice drug for lung or disseminated disease or itraconazole for 3 to 6 months even there is not a consensus on the length of the treatment.
CONCLUSION: We present one of the very few case reports in world literature of pure tracheal histoplasmosis probably associated with chronic steroids use in upper airway. This is a very unusual complication that must be considered as a differential diagnosis in upper airway obstruction.
Article visits 39 | PDF visits 82
Downloads
- Restrepo A. Histoplasmosis. En: Restrepo A.; Robledo J.; Bedoya V.; Restrepo M.; Botero D.; Leiderman E.; Betancur J.; Gómez C.; Vélez E. Enfermedades Infecciosas, Medellín, Colombia 1998, 287-96.
- Bennet J. Histoplasmosis. En: Fauci A. Braunwald E.; Isselbacher K.; Wilson J.; et al. Principle of Internal Medicine, Volume I, 1317-21
- Chang R. Histoplasmosis, Department of internal Medicine, Division of Pulmonary Critical Care. Emedicine, September 2005, 488-94
- Wheat J. Current diagnosis of histoplasmosis. Trends in Microbiology, Vol. 11. N. 10, October 2003, 488-94
- Sarosi GA., Johnson PC. Disseminated histoplasmosis in patients infected with human immunodeficiency virus. Clin Infect Dis. 1992;14: 60-67
- Shelburne S., Visnegarwala F., Adams C., Krause K., Mill R., White, C. Unusual manifestation of disseminated Histoplasmosis in patients responding to antiretroviral therapy”. The American Journal of Medicine, 2005, 118, 1038-41.
- Johnson PC., Khardori N., Najjar AF. Progressive disseminated histoplasmosis in patients with acquired immunodeficiency syndrome. Am J Med, 1998;85:152-58
- Thompson GR., Lavalle CE., Everett ED., Unusual manifestations of histoplasmosis Deparment of internal medicine, University of Missouri, USA, Diagnostic Microbiology and Infectious Disease, 2004, 33-41
- Gangat N., Lin Y., Elkin P. 68-year-old Man with Fatigue, fever, and Weight Loss. Mayo clinic proceedings, 2005, July, 939-42.
- Larsen CG., Militsakh O., Fang F., Tawfik O., Wallace I. Histoplasmosis presenting a upper airway Obstruccion, Department of Otolaryngology –head and neck surgery. 2005 vol 132, N.3 514-16
- Rousseau A., Cornet M., Carnot F., Brasnu D., Bruneval P., Badoul C. Mycosis of the head and neck, Ann Pathology. 2005, april;25(2): 104-16
- Wheat J, Hafner R, Korzun AH, Limjoco MT, et al. Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trial Group. Am J Med 1995 Apr;98(4):336-42.
- Dismukes WE; Bradsher RW Jr; Cloud GC; Kauffman CA. Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group. Am J Med 1995 Apr;98(4):336-42.
- Wheat LJ; Cloud G; Johnson PC; Connolly P; Goldman M; et al. Clearance of fungal burden during treatment of disseminated histoplasmosis with liposomal amphotericin B versus itraconazole. Antimicrob Agents Chemother 2001 Aug;45(8):2354-7.
- Wheat J; Sarosi G; McKinsey D; Hamill R; Bradsher R; Johnson P; Loyd J; Kauffman C. Practice guidelines for the management of patients with histoplasmosis. Infectious Diseases Society of America. Clin Infect Dis 2000 Apr;30(4):688-95.